BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34130044)

  • 1. Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.
    Borg M; Wen SWC; Nederby L; Hansen TF; Jakobsen A; Andersen RF; Weinreich UM; Hilberg O
    Lung Cancer; 2021 Aug; 158():85-90. PubMed ID: 34130044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.
    Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S
    BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice.
    Jett JR; Peek LJ; Fredericks L; Jewell W; Pingleton WW; Robertson JF
    Lung Cancer; 2014 Jan; 83(1):51-5. PubMed ID: 24268382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
    Wu WY; Haider Z; Feng X; Heath AK; Tjønneland A; Agudo A; Masala G; Robbins HA; Huerta JM; Guevara M; Schulze MB; Rodriguez-Barranco M; Vineis P; Tumino R; Kaaks R; Fortner RT; Sieri S; Panico S; Nøst TH; Sandanger TM; Braaten T; Johansson M; Melin B; Johansson M
    Int J Cancer; 2023 May; 152(9):2002-2010. PubMed ID: 36305647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
    Sullivan FM; Mair FS; Anderson W; Armory P; Briggs A; Chew C; Dorward A; Haughney J; Hogarth F; Kendrick D; Littleford R; McConnachie A; McCowan C; McMeekin N; Patel M; Rauchhaus P; Ritchie L; Robertson C; Robertson J; Robles-Zurita J; Sarvesvaran J; Sewell H; Sproule M; Taylor T; Tello A; Treweek S; Vedhara K; Schembri S;
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and blood based biomarkers for lung cancer screening: a systematic review.
    Chu GCW; Lazare K; Sullivan F
    BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.
    Macdonald IK; Murray A; Healey GF; Parsy-Kowalska CB; Allen J; McElveen J; Robertson C; Sewell HF; Chapman CJ; Robertson JF
    PLoS One; 2012; 7(12):e51002. PubMed ID: 23272083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
    White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
    Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
    Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can autoantibody tests enhance lung cancer screening?-an evaluation of EarlyCDT
    González Maldonado S; Johnson T; Motsch E; Delorme S; Kaaks R
    Transl Lung Cancer Res; 2021 Jan; 10(1):233-242. PubMed ID: 33569307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
    Edelsberg J; Weycker D; Atwood M; Hamilton-Fairley G; Jett JR
    PLoS One; 2018; 13(5):e0197826. PubMed ID: 29787590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer detection with digital chest tomosynthesis: baseline results from the observational study SOS.
    Terzi A; Bertolaccini L; Viti A; Comello L; Ghirardo D; Priotto R; Grosso M;
    J Thorac Oncol; 2013 Jun; 8(6):685-92. PubMed ID: 23612466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening--comparison of computed tomography and X-ray.
    Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
    Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
    Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
    J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
    Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
    BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.
    Leleu O; Basille D; Auquier M; Clarot C; Hoguet E; Pétigny V; Addi AA; Milleron B; Chauffert B; Berna P; Jounieaux V
    Clin Lung Cancer; 2020 Mar; 21(2):145-152. PubMed ID: 31982356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.